KATWIJK CHEMIE BV

Overview

KATWIJK CHEMIE BV is an active pharmaceutical ingredient (API) supplier with 10 active FDA Type II Drug Master Files, covering 1,2-DIMETHYL-3-HYDROXY-PYRIDONE-4 (DEFERIPRONE); DIVALPROEX SODIUM; ETHOSUXIMIDE; OXAPROZIN; PEMOLINE; PHENYTOIN/PHENYTOIN SODIUM.

API / Drug Master Files

KATWIJK CHEMIE BV holds 10 active (10 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• SODIUM VALPROATE POWDERActive2005-01-12
• DIVALPROEX SODIUMActive2002-12-11
• 1,2-DIMETHYL-3-HYDROXY-PYRIDONE-4 (DEFERIPRONE)Active1999-08-06
• PEMOLINEActive1995-12-24
• SODIUM VALPROATE CRYSTALSActive1995-12-24
• OXAPROZINActive1995-01-18
• ETHOSUXIMIDEActive1989-02-16
• VALPROIC ACIDActive1986-06-18
• SULFACETAMIDE/SULFACETAMIDE SODIUMActive1984-06-06
• PHENYTOIN/PHENYTOIN SODIUMActive1984-06-06

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to KATWIJK CHEMIE BV in our records. PharmaTek screens the full directory against live FDA enforcement data.